Access to durable LVAD therapy for patients with limited social support: Surveying program-specific approaches.

Autor:	Wald JW; Division of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania., Bennett M; Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota., Chou J; MedStar Health Research Institute, Hyattsville, Maryland., Pal JD; Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington., Ravichandran A; St. Vincent Heart Center of Indiana, Indianapolis, Indiana., Echols MR; Division of Cardiovascular Medicine, Morehouse School of Medicine, Atlanta, Georgia., Masser KS; Abbott Laboratories, Abbott Park, Illinois., Sheikh FH; Department of Cardiology, MedStar Heart and Vascular Institute, Georgetown University, Washington, District of Columbia., Sayer G; Division of Cardiology, Columbia University Irving Medical Center, New York, New York. Electronic address: gts2102@cumc.columbia.edu.
Jazyk:	angličtina
Zdroj:	The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation [J Heart Lung Transplant] 2024 Jun; Vol. 43 (6), pp. 996-998. Date of Electronic Publication: 2024 Feb 10.
DOI:	10.1016/j.healun.2024.02.001
Abstrakt:	Racial and ethnic disparities in provision of left ventricular assist device (LVAD) therapy have been identified. These disparities may be at least partially related to socioeconomic factors, including social support networks and financial constraints. This study aimed to identify specific barriers, and variations in institutional approaches, to the provision of equitable care to underserved populations. A survey was administered to 237 LVAD program personnel, including physicians, LVAD coordinators, and social workers, at more than 100 LVAD centers across 7 countries. Three fourths of respondents reported that their program required a support person to live with the LVAD patient for some period of time following implantation. In addition, 31% of respondents reported that patients with the inability to pay for medications are turned down at their program. The most significant barriers to successful LVAD implantation were lack of social support, lack of insurance, and lack of timely referral. The most consistently identified supports needed from the hospital system for success in underserved populations were the provision of a solution for patient transportation to and from hospital visits and the provision of financial support. This survey highlights the challenges facing LVAD programs that care for underserved patient populations and sets the stage for specific interventions aimed at reducing disparities in access to care. (Copyright © 2024 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu